Comparison 6. BDP v BUD crossover design, OCS treated patients, non OCS sparing.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Morning PEFR (L/min)	3	144	Mean Difference (IV, Fixed, 95% CI)	3.15 [‐30.72, 37.01]
2 Evening PEFR (L/min)	3	144	Mean Difference (IV, Fixed, 95% CI)	4.68 [‐29.03, 38.38]
3 Daytime breathlessness score	3	144	Std. Mean Difference (IV, Fixed, 95% CI)	‐0.03 [‐0.36, 0.29]
4 Night‐time breathlessness score	3	144	Std. Mean Difference (IV, Fixed, 95% CI)	‐0.08 [‐0.41, 0.24]
5 Sleeping difficulty due to asthma score	3	144	Std. Mean Difference (IV, Fixed, 95% CI)	0.08 [‐0.25, 0.40]
6 Rescue beta2 agonist use (puffs/d)	3	144	Mean Difference (IV, Fixed, 95% CI)	0.13 [‐0.70, 0.96]